Two-Dimensional Antimonene-Based Photonic Nanomedicine for Cancer Theranostics

© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 30(2018), 38 vom: 20. Sept., Seite e1802061
1. Verfasser: Tao, Wei (VerfasserIn)
Weitere Verfasser: Ji, Xiaoyuan, Zhu, Xianbing, Li, Li, Wang, Junqing, Zhang, Ye, Saw, Phei Er, Li, Wenliang, Kong, Na, Islam, Mohammad Ariful, Gan, Tian, Zeng, Xiaowei, Zhang, Han, Mahmoudi, Morteza, Tearney, Guillermo J, Farokhzad, Omid C
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article antimonene cancer theranostics drug delivery nanomedicine two-dimensional nanosheets
LEADER 01000naa a22002652 4500
001 NLM286836432
003 DE-627
005 20231225052643.0
007 cr uuu---uuuuu
008 231225s2018 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.201802061  |2 doi 
028 5 2 |a pubmed24n0956.xml 
035 |a (DE-627)NLM286836432 
035 |a (NLM)30043416 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Tao, Wei  |e verfasserin  |4 aut 
245 1 0 |a Two-Dimensional Antimonene-Based Photonic Nanomedicine for Cancer Theranostics 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 07.03.2019 
500 |a Date Revised 13.11.2023 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
520 |a Antimonene (AM) is a recently described two-dimensional (2D) elemental layered material. In this study, a novel photonic drug-delivery platform based on 2D PEGylated AM nanosheets (NSs) is developed. The platform's multiple advantages include: i) excellent photothermal properties, ii) high drug-loading capacity, iii) spatiotemporally controlled drug release triggered by near-infrared (NIR) light and moderate acidic pH, iv) superior accumulation at tumor sites, v) deep tumor penetration by both extrinsic stimuli (i.e., NIR light) and intrinsic stimuli (i.e., pH), vi) excellent multimodal-imaging properties, and vii) significant inhibition of tumor growth with no observable side effects and potential degradability, thus addressing several key limitations of cancer nanomedicines. The intracellular fate of the prepared NSs is also revealed for the first time, providing deep insights that improve cellular-level understanding of the nano-bio interactions of AM-based NSs and other emerging 2D nanomaterials. To the best of knowledge, this is the first report on 2D AM-based photonic drug-delivery platforms, possibly marking an exciting jumping-off point for research into the application of 2D AM nanomaterials in cancer theranostics 
650 4 |a Journal Article 
650 4 |a antimonene 
650 4 |a cancer theranostics 
650 4 |a drug delivery 
650 4 |a nanomedicine 
650 4 |a two-dimensional nanosheets 
700 1 |a Ji, Xiaoyuan  |e verfasserin  |4 aut 
700 1 |a Zhu, Xianbing  |e verfasserin  |4 aut 
700 1 |a Li, Li  |e verfasserin  |4 aut 
700 1 |a Wang, Junqing  |e verfasserin  |4 aut 
700 1 |a Zhang, Ye  |e verfasserin  |4 aut 
700 1 |a Saw, Phei Er  |e verfasserin  |4 aut 
700 1 |a Li, Wenliang  |e verfasserin  |4 aut 
700 1 |a Kong, Na  |e verfasserin  |4 aut 
700 1 |a Islam, Mohammad Ariful  |e verfasserin  |4 aut 
700 1 |a Gan, Tian  |e verfasserin  |4 aut 
700 1 |a Zeng, Xiaowei  |e verfasserin  |4 aut 
700 1 |a Zhang, Han  |e verfasserin  |4 aut 
700 1 |a Mahmoudi, Morteza  |e verfasserin  |4 aut 
700 1 |a Tearney, Guillermo J  |e verfasserin  |4 aut 
700 1 |a Farokhzad, Omid C  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 30(2018), 38 vom: 20. Sept., Seite e1802061  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:30  |g year:2018  |g number:38  |g day:20  |g month:09  |g pages:e1802061 
856 4 0 |u http://dx.doi.org/10.1002/adma.201802061  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 30  |j 2018  |e 38  |b 20  |c 09  |h e1802061